Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma.

Tian D, Yang L, Wang S, Zhu Y, Shi W, Zhang C, Jin H, Tian Y, Xu H, Sun G, Liu K, Zhang Z, Zhang D.

Nat Commun. 2019 Sep 18;10(1):4246. doi: 10.1038/s41467-019-12243-0.

2.
3.

Regulation of allergic airway inflammation by adoptive transfer of CD4+ T cells preferentially producing IL-10.

Matsuda M, Doi K, Tsutsumi T, Fujii S, Kishima M, Nishimura K, Kuroda I, Tanahashi Y, Yuasa R, Kinjo T, Kuramoto N, Mizutani N, Nabe T.

Eur J Pharmacol. 2017 Oct 5;812:38-47. doi: 10.1016/j.ejphar.2017.06.037. Epub 2017 Jun 29.

PMID:
28668505
4.
5.

PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function.

Ghonim MA, Pyakurel K, Ibba SV, Al-Khami AA, Wang J, Rodriguez P, Rady HF, El-Bahrawy AH, Lammi MR, Mansy MS, Al-Ghareeb K, Ramsay A, Ochoa A, Naura AS, Boulares AH.

J Transl Med. 2015 Jul 14;13:225. doi: 10.1186/s12967-015-0583-0.

6.

Cytokine gene-modulated dendritic cells protect against allergic airway inflammation by inducing IL-10(+)IFN-gamma(+)CD4(+) T cells.

Hsu CY, Leu SJ, Chiang BL, Liu HE, Su HC, Lee YL.

Gene Ther. 2010 Aug;17(8):1011-21. doi: 10.1038/gt.2010.39. Epub 2010 Apr 1.

PMID:
20357831
7.
8.

Pentraxin 3 deletion aggravates allergic inflammation through a TH17-dominant phenotype and enhanced CD4 T-cell survival.

Balhara J, Shan L, Zhang J, Muhuri A, Halayko AJ, Almiski MS, Doeing D, McConville J, Matzuk MM, Gounni AS.

J Allergy Clin Immunol. 2017 Mar;139(3):950-963.e9. doi: 10.1016/j.jaci.2016.04.063. Epub 2016 Jul 26.

9.

Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma.

Moerch U, Haahr Hansen M, Vest Hansen NJ, Rasmussen LK, Oleksiewicz MB, Frandsen TP, Haurum JS, Bregenholt S.

Int Arch Allergy Immunol. 2006;140(3):261-9. Epub 2006 May 11.

PMID:
16699287
10.

Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells.

Ishikawa Y, Kobayashi K, Yamamoto M, Nakata K, Takagawa T, Funada Y, Kotani Y, Karasuyama H, Yoshida M, Nishimura Y.

Respir Res. 2011 Apr 10;12:42. doi: 10.1186/1465-9921-12-42.

11.

The inhibitory effects of intravenous administration of rabbit immunoglobulin G on airway inflammation are dependent upon Fcγ receptor IIb on CD11c(+) dendritic cells in a murine model.

Yamamoto M, Kobayashi K, Ishikawa Y, Nakata K, Funada Y, Kotani Y, Masuda A, Takai T, Azuma T, Yoshida M, Nishimura Y.

Clin Exp Immunol. 2010 Nov;162(2):315-24. doi: 10.1111/j.1365-2249.2010.04243.x. Epub 2010 Sep 1.

12.

DNA-dependent protein kinase inhibition blocks asthma in mice and modulates human endothelial and CD4⁺ T-cell function without causing severe combined immunodeficiency.

Ghonim MA, Pyakurel K, Ju J, Rodriguez PC, Lammi MR, Davis C, Abughazleh MQ, Mansy MS, Naura AS, Boulares AH.

J Allergy Clin Immunol. 2015 Feb;135(2):425-40. doi: 10.1016/j.jaci.2014.09.005. Epub 2014 Oct 19.

13.

Regulation of Th2 responses and allergic inflammation through bystander activation of CD8+ T lymphocytes in early life.

Dubois A, Deruytter N, Adams B, Kanda A, Delbauve S, Fleury S, Torres D, François A, Pétein M, Goldman M, Dombrowicz D, Flamand V.

J Immunol. 2010 Jul 15;185(2):884-91. doi: 10.4049/jimmunol.0903287. Epub 2010 Jun 18.

14.

Role of IL-4 receptor α-positive CD4(+) T cells in chronic airway hyperresponsiveness.

Kirstein F, Nieuwenhuizen NE, Jayakumar J, Horsnell WGC, Brombacher F.

J Allergy Clin Immunol. 2016 Jun;137(6):1852-1862.e9. doi: 10.1016/j.jaci.2015.10.036. Epub 2015 Dec 11.

PMID:
26688514
15.

Phenotype analyses of IL-10-producing Foxp3- CD4+ T cells increased by subcutaneous immunotherapy in allergic airway inflammation.

Matsuda M, Morie Y, Oze H, Doi K, Tsutsumi T, Hamaguchi J, Inaba M, Nabe T.

Int Immunopharmacol. 2018 Aug;61:297-305. doi: 10.1016/j.intimp.2018.06.014. Epub 2018 Jun 14.

PMID:
29909233
16.

Yan-Hou-Qing formula attenuates allergic airway inflammation via up-regulation of Treg and suppressing Th2 responses in Ovalbumin-induced asthmatic mice.

Cheng BH, Hu TY, Mo LH, Ma L, Hu WH, Li YS, Liu ZQ, Qiu SQ.

J Ethnopharmacol. 2019 Mar 1;231:275-282. doi: 10.1016/j.jep.2018.11.038. Epub 2018 Nov 26.

PMID:
30496840
17.

Fcgamma receptor-mediated antigen uptake by lung DC contributes to allergic airway hyper-responsiveness and inflammation.

Hartwig C, Mazzega M, Constabel H, Krishnaswamy JK, Gessner JE, Braun A, Tschernig T, Behrens GM.

Eur J Immunol. 2010 May;40(5):1284-95. doi: 10.1002/eji.200939900.

18.

Transfer of allergic airway responses with antigen-primed CD4+ but not CD8+ T cells in brown Norway rats.

Watanabe A, Mishima H, Renzi PM, Xu LJ, Hamid Q, Martin JG.

J Clin Invest. 1995 Sep;96(3):1303-10.

19.

Opposite effects of immunotherapy with ovalbumin and the immunodominant T-cell epitope on airway eosinophilia and hyperresponsiveness in a murine model of allergic asthma.

Janssen EM, Wauben MH, Jonker EH, Hofman G, Van Eden W, Nijkamp FP, Van Oosterhout AJ.

Am J Respir Cell Mol Biol. 1999 Jul;21(1):21-9.

PMID:
10385589
20.

Regulation of IgE production and airway reactivity by CD4⁻CD8⁻ regulatory T cells.

Raker V, Stein J, Montermann E, Maxeiner J, Taube C, Reske-Kunz AB, Sudowe S.

Immunobiology. 2015 Apr;220(4):490-9. doi: 10.1016/j.imbio.2014.10.022. Epub 2014 Oct 30.

PMID:
25468560

Supplemental Content

Support Center